Other News To Note
Friday, August 12, 2011
Neoprobe Corp., of Dublin, Ohio, submitted a new drug application to the FDA for Lymphoseek (tilmanocept) for use in intraoperative lymphatic mapping. The procedure, which identifies and biopsies lymph nodes draining the area around a tumor, is used primarily in melanoma and breast cancer.
Sign up for Perspectives FREE e-mail newsletter.
Outside the U.S.: 1-404-262-5476
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.